Gestational Diabetes and Antenatal Human Milk Expression
The Effects and Experience of a Gestational Diabetes and Antenatal Human Milk Expression (GAME) Programme in Hong Kong Chinese Women
1 other identifier
interventional
246
1 country
2
Brief Summary
Exclusive breastfeeding is global recognized as the optimal infant feeding. Hong Kong is committed to promoting, protecting and supporting the global movement for successful breastfeeding. Exclusive breastfeeding is especially strongly recommended and supported to the maternal history of Gestational Diabetes Mellitus (GDM). This study aims to examine the acceptability and feasibility of Antenatal human milk expression (AME) as breastfeeding intervention to improve breastfeeding for GDM women. The efficacy of AME practice on the breastfeeding exclusivity will also be investigated. It is hypothesized that AME will increase breastfeeding exclusivity compare with women receiving standard care, and will improve the breastfeeding self-efficacy and reduce depressive symptoms of women after birth.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2023
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 17, 2023
CompletedFirst Posted
Study publicly available on registry
May 10, 2023
CompletedStudy Start
First participant enrolled
May 10, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 10, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 10, 2024
CompletedSeptember 19, 2024
April 1, 2023
1 year
April 17, 2023
September 11, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Infant Feeding pattern
Exclusive breastfeeding prevalence
At 4 weeks postpartum
Infant Feeding pattern
Exclusive breastfeeding prevalence
At 8 weeks postpartum
Secondary Outcomes (4)
Women's self-determination toward breastfeeding
At baseline, 4 weeks and 8 weeks postpartum
Women's self-efficacy in breastfeeding
At baseline, 4 weeks and 8 weeks postpartum
Women's perinatal/postnatal depression
At baseline, 4 weeks and 8 weeks postpartum
Women's prevalence of Impaired Glucose Tolerance
At 6 weeks postpartum
Other Outcomes (1)
Women's experience, perception, and attitude for AME practices
At 6 weeks postpartum
Study Arms (2)
Standard care plus an antenatal milk expression education
EXPERIMENTALParticipants will have one face-to-face breastfeeding education in lactation clinic at 37 weeks of gestation and telephone follow-up weekly till delivery.
Standard hospital antenatal care
NO INTERVENTIONParticipants will receive standard care include prenatal breastfeeding education at gestation of 24-36 weeks same as intervention group. They will not discuss about antenatal milk expression, breastfeeding self-efficacy and the effects of breastfeeding on GDM women.
Interventions
A face-to-face breastfeeding education in lactation clinic at 37 weeks of gestation will be arranged. The session will approximately last for 45minutes. GDM leaflet and GAME fact sheet are used to facilitate the teaching. The benefits of breastfeeding for women with GDM will be addressed. Maternal metabolic control, calories consumed, and weight loss are addressed for the extra benefits of breastfeeding for GDM women. The possible challenges of GDM on breastfeeding will be supported. The antenatal human milk expression will be taught by International Board-Certified Lactation Consultant. Participants will be encouraged to express colostrum twice daily for up to 10 minutes until admitted to hospital to give birth. They will receive a weekly phone follows up from 38 weeks before delivery and they can contact the researcher by phone in the information sheet if any questions.
Eligibility Criteria
You may qualify if:
- diagnosed gestational diabetes without on insulin
- can read and speak Chinese
- Hong Kong resident and stay in Hong Kong after delivery
- no serious medical or obstetrical complications
- no mental health illness or history
- have regular antenatal check-up
- singleton pregnancy
- primiparous or multiparous women
- intention to breastfeed
- pre-pregnancy BMI\<25
You may not qualify if:
- do not have Hong Kong Identify Card
- breastfeeding elder child at pregnancy
- cannot understand the study
- give birth \<37 weeks of gestation
- a known fetal anomaly or any suspicion of fetal compromise
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Kwong Wah Hospital
Hong Kong, Hong Kong
Queen Elizabeth Hospital
Hong Kong, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yu Ngai Ms Leung, MPH
Department of Obstetrics and Gynaecology, Kwong Wah Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 17, 2023
First Posted
May 10, 2023
Study Start
May 10, 2023
Primary Completion
May 10, 2024
Study Completion
May 10, 2024
Last Updated
September 19, 2024
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share